Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Fluoxetine and suicidal preoccupation

Fluoxetine and suicidal preoccupation SIR:Suicidal H. Teicher,Preoccupation M.D., and associates ( 1 ) reportedlarge novopatient intensepopulations are suicidal ideationsnecessary arc a sideto confirm that effect of fluoxctinc.the emergence of intense suicidal preoccupation during fluoxetine treatment, with an estimated incidence of 1.3%-7.S%. We reviewed all patients who received fluoxetinc from the outpatient pharmacy at a Veterans Administration hospitalduring the period ofApnil 1989 to April 1991. Policy dictatedREFERENCES 1. Teicher MH, Glod C, Cole JO: Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990; 147:207-210 2. Fava M, Rosenbaum JF: Suicidality and fluoxetine: is there a relationship? in New Research Program and Abstracts, 143rd Annual Meeting of the American Psychiatric Association. Washington, DC, APA, I 990 E. ALEXANDRA ASHLEIGH, F. ANNE FESLER, Seattle, M.D M.D. Wash.that patients must have failed more traditional pharmacotherapy or have another clear indication for use of fluoxetinc. Fluoxetinc was prescribed for 255 patients. Of these, six patients did not take the fluoxetinc. Of the remaining 249, foblow-up was obtained for 206, or 82%. One hundred thirty-six patients were studied retrospectively, and 71 patients werestudied prospectively (beginning August 1990). Information change in suiIn those fewwas providedby the treatingphysician.history during and any treatment.Physicians reported suicide cidal or homicidal http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Psychiatry American Psychiatric Publishing, Inc (Journal)

Fluoxetine and suicidal preoccupation

American Journal of Psychiatry , Volume 149 (12) – Dec 1, 1992

Fluoxetine and suicidal preoccupation

American Journal of Psychiatry , Volume 149 (12) – Dec 1, 1992

Abstract

SIR:Suicidal H. Teicher,Preoccupation M.D., and associates ( 1 ) reportedlarge novopatient intensepopulations are suicidal ideationsnecessary arc a sideto confirm that effect of fluoxctinc.the emergence of intense suicidal preoccupation during fluoxetine treatment, with an estimated incidence of 1.3%-7.S%. We reviewed all patients who received fluoxetinc from the outpatient pharmacy at a Veterans Administration hospitalduring the period ofApnil 1989 to April 1991. Policy dictatedREFERENCES 1. Teicher MH, Glod C, Cole JO: Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990; 147:207-210 2. Fava M, Rosenbaum JF: Suicidality and fluoxetine: is there a relationship? in New Research Program and Abstracts, 143rd Annual Meeting of the American Psychiatric Association. Washington, DC, APA, I 990 E. ALEXANDRA ASHLEIGH, F. ANNE FESLER, Seattle, M.D M.D. Wash.that patients must have failed more traditional pharmacotherapy or have another clear indication for use of fluoxetinc. Fluoxetinc was prescribed for 255 patients. Of these, six patients did not take the fluoxetinc. Of the remaining 249, foblow-up was obtained for 206, or 82%. One hundred thirty-six patients were studied retrospectively, and 71 patients werestudied prospectively (beginning August 1990). Information change in suiIn those fewwas providedby the treatingphysician.history during and any treatment.Physicians reported suicide cidal or homicidal

Loading next page...
 
/lp/american-psychiatric-publishing-inc-journal/fluoxetine-and-suicidal-preoccupation-6kCERPYo72

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Psychiatric Publishing, Inc (Journal)
Copyright
Copyright © American Psychiatric Association. All rights reserved
ISSN
0002-953X
Publisher site
See Article on Publisher Site

Abstract

SIR:Suicidal H. Teicher,Preoccupation M.D., and associates ( 1 ) reportedlarge novopatient intensepopulations are suicidal ideationsnecessary arc a sideto confirm that effect of fluoxctinc.the emergence of intense suicidal preoccupation during fluoxetine treatment, with an estimated incidence of 1.3%-7.S%. We reviewed all patients who received fluoxetinc from the outpatient pharmacy at a Veterans Administration hospitalduring the period ofApnil 1989 to April 1991. Policy dictatedREFERENCES 1. Teicher MH, Glod C, Cole JO: Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990; 147:207-210 2. Fava M, Rosenbaum JF: Suicidality and fluoxetine: is there a relationship? in New Research Program and Abstracts, 143rd Annual Meeting of the American Psychiatric Association. Washington, DC, APA, I 990 E. ALEXANDRA ASHLEIGH, F. ANNE FESLER, Seattle, M.D M.D. Wash.that patients must have failed more traditional pharmacotherapy or have another clear indication for use of fluoxetinc. Fluoxetinc was prescribed for 255 patients. Of these, six patients did not take the fluoxetinc. Of the remaining 249, foblow-up was obtained for 206, or 82%. One hundred thirty-six patients were studied retrospectively, and 71 patients werestudied prospectively (beginning August 1990). Information change in suiIn those fewwas providedby the treatingphysician.history during and any treatment.Physicians reported suicide cidal or homicidal

Journal

American Journal of PsychiatryAmerican Psychiatric Publishing, Inc (Journal)

Published: Dec 1, 1992

There are no references for this article.